glutathione conjugates reaction 16 Phase II reactions Conjugation with GSH paracetamol Phase II - Glutathione Conjugation
Description
S2CID 120110443
Unlike GLP-1 agonists, it targets amylin receptors, making it a unique tool for studying complementary appetite-regulating pathways
Several developments could significantly advance understanding of this compound in the coming years
Michael Conlon describe the scope of it: In clinical trials, CagriSema has achieved greater effects than either component [cagrilintide or semaglutide] alone
A company like BIOCROWN gives them something very important at the start: the feeling that the manufacturing side is under control
